Faron Pharmaceuticals Oy EBITDA for the year ending December 31, 2024: USD -19.12 K

Faron Pharmaceuticals Oy EBITDA is USD -19.12 K for the year ending December 31, 2024, a -99.94% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Faron Pharmaceuticals Oy EBITDA for the year ending December 31, 2023 was USD -31.31 M, a 8.17% change year over year.
  • Faron Pharmaceuticals Oy EBITDA for the year ending December 31, 2022 was USD -28.95 M, a 23.11% change year over year.
  • Faron Pharmaceuticals Oy EBITDA for the year ending December 31, 2021 was USD -23.51 M, a 16.65% change year over year.
  • Faron Pharmaceuticals Oy EBITDA for the year ending December 31, 2020 was USD -20.16 M, a 40.45% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)